| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.001 |